Scientists in Japan have revealed that fish oil can help to protect against damage caused by heart disease.
In a study involving more than 18,600 participants who have all suffered from high levels of cholesterol, the researchers found that those who were given the fish oil fatty acid EPA were 19 per cent less likely to suffer from non-fatal heart attacks or require surgical procedure such as artery widening or by-passes than those who had just taken satins without the EPA.
With the results of the five year study published in the Lancet medical journal, the research team have revealed that only 2.8 per cent of patients who had taken EPA had experienced a major coronary incident over the period, in comparison to 3.5 per cent of those who had not taken the EPA.
"This study shows that EPA, at a dose of 1,800 milligrams per day is a very promising regimen for prevention of major coronary events," said Professor Mitsuhiro Yokoyama, who led the study.
These latest results follow on from several previous studies which have linked EPA, eliosapentaenoic acid, and its fish oil fatty acid equivalent DHA, with a reduced risk of death from heart disease.
What's better? Private or NHS healthcare?